| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viatris Inc | Chief Commercial Officer | Restricted Stock Units | 110K | $1.33M | $12.09 | Apr 18, 2024 | Direct |
| Imunon, Inc. | President and CEO, Director | Stock Option (Right to Buy) | 320K | Mar 17, 2023 | Direct | ||
| Longboard Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 22.5K | May 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LBPH | Longboard Pharmaceuticals, Inc. | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| VTRS | Viatris Inc | Apr 18, 2024 | 2 | $0 | 4 | Apr 19, 2024 | Chief Commercial Officer |
| VTRS | Viatris Inc | Apr 15, 2024 | 0 | $0 | 3 | Apr 19, 2024 | Chief Commercial Officer |
| LBPH | Longboard Pharmaceuticals, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| IMNN | Imunon, Inc. | Mar 17, 2023 | 1 | $0 | 4 | Mar 21, 2023 | President and CEO, Director |
| IMNN | Celsion CORP | Jul 18, 2022 | 2 | $0 | 4 | Jul 20, 2022 | President and CEO, Director |
| IMNN | Celsion CORP | Jul 18, 2022 | 0 | $0 | 3 | Jul 20, 2022 | President and CEO, Director |
| LBPH | Longboard Pharmaceuticals, Inc. | May 24, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |